Emergent Biosolutions Inc. - EBS (NYSE)

52.33
1.30 (-2.42%)
Quotes delayed 15 mins. Currently June 21, 2018 9:23:17 PM
By signing up, you can buy this stock for just $4.95 or purchase it within a Motif
Emergent BioSolutions develops vaccines and antibody therapeutics to treat cancer and inflammatory disorders

Key Financials

Day Range:52.16 - 53.68
52 Week Range:32.35 - 55.94
Open:53.68
Shares:49.82M
Market Cap:2.61B
EPS:1.37
P/E Ratio:39.10
Div Yield:--
Performance
Previous close
No Chart Available
Purchase EBS in a Motif
A motif is an intelligently weighted basket of up to 30 stocks and ETFs built around themes and investing styles.
On our platform, you can buy shares of EBS not only as a single stock, but also as part of a motif.
Professional Motifs with EBS
Kings of K Street
Kings of K Street 19.0% 1 YR RTN The companies that do the most political lobbying may have the potential for peak performance.
View all professional motifs with EBS
Community Motifs with EBS
Biotechnology
Biotechnology 28.3% 1 YR RTN
Hot Biotechs
Hot Biotechs -- 1 YR RTN
Technological Panacea
Technological Panacea 20.7% 1 YR RTN
View all community motifs with EBS
What Others Think About EBS
US Banking News
Analysts Anticipate Emergent Biosolutions Inc $EBS to Post $0.96 Earnings Per Share americanbankingnews.com/?p=7135886 #stocks
shortvolumes
Short sale vol (not short interest) for $NVAX on 2018-06-19 is 58%. shortvolumes.com/?t=NVAX $NVS 21% $EBS 46% $AGEN 38% $PFE 68%
shortvolumes
Short sale vol (not short interest) for $CLDX on 2018-06-19 is 44%. shortvolumes.com/?t=CLDX $EBS 46% $BMY 32% $GSK 54% $PFE 68%
shortvolumes
Short sale vol (not short interest) for $CLDX on 2018-06-19 is 44%. shortvolumes.com/?t=CLDX $PFE 68% $BMY 32% $EBS 46% $AGEN 38%
shortvolumes
Short sale vol (not short interest) for $NVAX on 2018-06-18 is 40%. shortvolumes.com/?t=NVAX $EBS 43% $PFE 66% $AGEN 51% $SRPT 52%
US Banking News
Emergent Biosolutions $EBS Stock Rating Reaffirmed by Cantor Fitzgerald americanbankingnews.com/?p=7114303 #stocks
finzine
$MS $EBS Emerging-Market Chaos Poses Dilemma for Hungary's Central Bank via hvper.com/?ref=ftw
shortvolumes
Short sale vol (not short interest) for $NVAX on 2018-06-18 is 40%. shortvolumes.com/?t=NVAX $AGEN 51% $XLV 64% $SRPT 52% $EBS 43%
News About EBS
No Headlines available for EBS at this time.
Related Companies Within The Biotechnology Sector
Amgen Inc. - 185.99
AMGN
GILD
Biogen Inc. - 297.34
BIIB
CELG
SHPG
Shire plc - 162.40
SHPG